IBX 7.35% 6.3¢ imagion biosystems limited

Ann: Imagion Announces Positive Results from Phase 1 Study, page-22

  1. 638 Posts.
    lightbulb Created with Sketch. 93
    @reon1 - delusional is a correct summation.
    As a medical imaging scientist, IBX does nothing to excite me.
    This typical news release is constructed only to capture some sort of excitement for non scientists.
    I could write 1000 words explaining why this $ sucking company will go nowhere but I can’t be stuffed.
    I will say, as a supposedly bio tech, this management team are quite useless. I don’t agree with the way they construct their trials but that’s another matter, but their history of accomplishing these simple basic trials is woeful. To read that their timelines will be blown out again justifies my words.
    There is another biotech imaging/cancer care company currently progressing through their trials (which I don’t need to mention here) which can be used as a comparison in actually getting imaging trials successfully done in a very timely manner. I would regard its board of professionals as first rate.
    Management is everything and I would class IBX management as jokes.
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
(20min delay)
Last
6.3¢
Change
-0.005(7.35%)
Mkt cap ! $2.219M
Open High Low Value Volume
6.4¢ 6.4¢ 6.3¢ $1.18K 18.62K

Buyers (Bids)

No. Vol. Price($)
1 90 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.8¢ 1245 1
View Market Depth
Last trade - 15.56pm 17/07/2024 (20 minute delay) ?
IBX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.